GENETEC | GENETEC TECHNOLOGY BERHAD

0.280 (0.0%)
3 T-O (am): 0.285 (08:59:00)
Price updated as of: 16:52
Fundamental
Technical
Total Score
GENETEC | GENETEC TECHNOLOGY BERHAD

GENETEC Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Chart:

GENETEC Quarter Reports

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS		 Adj.
[M]		 NP [M]
(adj)		 NPM
(adj)		 EPS
(adj)		 E. QoQ
(adj)		 E. YoY
(adj)		 TTM EPS
(adj)
26 Nov 25 Q1 Sep 2025 1 30 Jun 2026 34.34 -42.30 -42.30 -123.2% 0.00 -5.46 23.4% 14.6% 7.5% 987.2%
28 Aug 25 Q4 Jun 2025 4 30 Jun 2025 44.80 -41.69 -45.71 -102.0% 0.00 -5.84 40.4% 13.0% 6122.7% 550.0%
29 May 25 Q3 Mar 2025 3 30 Jun 2025 75.12 3.15 0.76 1.0% 0.00 0.10 20.1% 6.6% 88.4% 95.5%
27 Feb 25 Q2 Dec 2024 2 30 Jun 2025 62.56 6.79 6.54 10.4% 0.00 0.84 55.6% 18.7% 37.1% 71.9%
26 Nov 24 Q1 Sep 2024 1 30 Jun 2025 40.20 4.43 4.77 11.9% 0.00 0.61 21.9% 44.5% 53.1% 74.2%
29 Aug 24 30 Jun 2024 Other 30 Jun 2024 51.49 7.63 10.16 19.7% 2.00 1.32 26.9% 32.0% 39.7% 41.5%
28 May 24 31 Mar 2024 Other 30 Jun 2024 70.47 19.06 16.84 23.9% 0.00 2.21 8.4% 10.1% 27.7% 1.5%
27 Feb 24 31 Dec 2023 Other 30 Jun 2024 76.91 25.16 23.29 30.3% 0.00 3.07 6.2% 9.7% 26.2% 82.5%
28 Nov 23 30 Sep 2023 Other 30 Jun 2024 72.44 18.75 18.45 25.5% 0.00 2.45 4.3% 2.5% 6.2% 26.4%
29 Aug 23 Q1 Jun 2023 1 31 Mar 2024 75.70 19.79 17.38 23.0% 0.00 2.32 3.4% 3.4% 1.7% 6.0%
31 May 23 Q4 Mar 2023 4 31 Mar 2023 78.39 19.03 17.09 21.8% 0.00 2.48 7.9% 33.5% 34.0% 25.4%
27 Feb 23 Q3 Dec 2022 3 31 Mar 2023 85.14 13.88 12.76 15.0% 0.00 1.87 20.5% 30.5% 49.1% 30.2%
28 Nov 22 Q2 Sep 2022 2 31 Mar 2023 70.66 27.94 25.05 35.5% 0.00 3.67 3.5% 19.1% 35.5% 53.6%
29 Aug 22 Q1 Jun 2022 1 31 Mar 2023 73.21 19.44 18.49 25.3% 0.00 2.71 24.7% 81.8% 35.7% 126.0%
26 May 22 Q4 Mar 2022 4 31 Mar 2022 58.70 14.84 13.63 23.2% 0.00 2.00 10.1% 349.3% 25.5% 339.7%
26 Jan 22 Q3 Dec 2021 3 31 Mar 2022 65.26 21.01 18.28 28.0% 0.00 35.83 10.0% 98.3% 12.1% 1956.5%
25 Oct 21 Q2 Sep 2021 2 31 Mar 2022 59.31 17.59 16.31 27.5% 0.00 32.25 47.3% 53.4% 99.3% 518.3%
29 Jul 21 Q1 Jun 2021 1 31 Mar 2022 40.28 8.86 8.18 20.3% 0.00 16.28 208.3% 224.1% 243.9% 491.7%
25 May 21 Q4 Mar 2021 4 31 Mar 2021 13.07 -6.56 -5.68 -43.5% 0.00 -13.03 60.3% 57.0% 739.5% 27.3%
09 Feb 21 Q3 Dec 2020 3 31 Mar 2021 32.91 0.84 0.89 2.7% 0.00 2.06 14.9% 17.9% 66.3% 89.5%
25 Nov 20 Q2 Sep 2020 2 31 Mar 2021 38.67 2.69 2.64 6.8% 0.00 6.18 211.2% 167.0% 226.3% 1489.2%
27 Aug 20 Q1 Jun 2020 1 31 Mar 2021 12.43 -1.79 -2.09 -16.8% 0.00 -4.93 49.4% 28.7% 73.3% 118.5%
24 Jun 20 Q4 Mar 2020 4 31 Mar 2020 8.32 -8.74 -7.82 -94.0% 0.00 -18.50 79.2% 42.0% 192.6% 109.6%
26 Feb 20 Q3 Dec 2019 3 31 Mar 2020 40.11 8.12 8.45 21.1% 0.00 19.97 176.9% 16.2% 4987.9% 69.2%
25 Nov 19 Q2 Sep 2019 2 31 Mar 2020 14.48 -0.19 0.17 1.1% 0.00 0.39 16.9% 25.7% 117.4% 75.5%
28 Aug 19 Q1 Jun 2019 1 31 Mar 2020 17.42 -0.51 -0.96 -5.5% 0.00 -2.26 21.4% 39.5% 74.4% 126.0%
28 May 19 Q4 Mar 2019 4 31 Mar 2019 14.36 -5.56 -3.73 -26.0% 0.00 -9.19 58.4% 50.6% 174.8% 2247.2%
26 Feb 19 Q3 Dec 2018 3 31 Mar 2019 34.52 5.06 4.99 14.5% 2.50 12.42 77.1% 25.7% 636.1% 83.3%
28 Nov 18 Q2 Sep 2018 2 31 Mar 2019 19.50 0.84 0.68 3.5% 0.00 1.71 32.3% 0.1% 81.6% 170.0%
21 Aug 18 Q1 Jun 2018 1 31 Mar 2019 28.79 3.89 3.68 12.8% 2.50 9.32 0.9% 14.9% 2412.6% 89.0%
22 May 18 Q4 Mar 2018 4 31 Mar 2018 29.05 0.19 -0.16 -0.6% 0.00 -0.44 5.8% 58.8% 105.8% 91.9%
28 Feb 18 Q3 Dec 2017 3 31 Mar 2018 27.47 3.66 2.72 9.9% 0.00 7.67 41.1% 91.3% 381.3% 221.9%
21 Nov 17 Q2 Sep 2017 2 31 Mar 2018 19.47 -0.53 -0.97 -5.0% 0.00 -2.72 22.3% 21.3% 149.8% 64.3%
29 Aug 17 Q1 Jun 2017 1 31 Mar 2018 25.05 2.58 1.95 7.8% 0.00 5.53 37.0% 14.2% 199.2% 110.3%
24 May 17 Q4 Mar 2017 4 31 Mar 2017 18.29 -2.01 -1.96 -10.7% 0.00 -5.57 27.4% 10.3% 12.3% 60.8%
24 Feb 17 Q3 Dec 2016 3 31 Mar 2017 14.36 -1.87 -2.23 -15.6% 0.00 -6.35 10.6% 27.5% 279.3% 9.7%
22 Nov 16 Q2 Sep 2016 2 31 Mar 2017 16.05 -0.52 -0.59 -3.7% 0.00 -1.67 26.8% 58.6% 163.7% 118.7%
24 Aug 16 Q1 Jun 2016 1 31 Mar 2017 21.93 0.81 0.93 4.2% 0.00 2.63 32.2% 59.3% 175.9% 79.5%
24 May 16 Q4 Mar 2016 4 31 Mar 2016 16.59 -0.09 -1.22 -7.3% 0.00 -3.47 16.2% 65.8% 40.2% 164.3%
24 Feb 16 Q3 Dec 2015 3 31 Mar 2016 19.80 -1.33 -2.04 -10.3% 0.00 -0.58 48.9% 49.6% 164.5% 230.5%
18 Nov 15 Q2 Sep 2015 2 31 Mar 2016 38.78 3.71 3.16 8.1% 0.00 0.90 28.0% 41.2% 29.9% 447.0%
19 Aug 15 Q1 Jun 2015 1 31 Mar 2016 53.84 5.97 4.50 8.4% 0.00 1.28 11.1% 75.6% 137.6% 967.1%
29 May 15 Q4 Mar 2015 4 31 Mar 2015 48.46 0.69 1.90 3.9% 0.00 0.54 23.3% 158.1% 21.4% 38.8%
13 Feb 15 31/12/14 3 31/03/15 39.30 1.70 1.56 4.0% 0.00 0.44 43.1% 63.6% 170.5% 619.4%

GENETEC Historical Dividends

GENETEC Financial Ratios

EPS -10.2 sen
Trailing PE (Sector Median: 28.5) 0.0
PEG 0.0
Altman Z 0.8
Beaver -0.32
Current Ratio 2.92
Debt-Equity (DE) Ratio 0.34
FCF Yield -21.38 %
Revenue QoQ -23.35 %
Revenue YoY -14.58%
Profit QoQ 7.46 %
Profit YoY -987.23 %
Profit Margin (Sector Median: 5.3) -37.23 %
ROE (ROIC: -20.65) -20.69 %
Dividend Per Share (DPS) 0.0 sen
Dividend Yield (DY) 0.0 %

GENETEC Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 28.5)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 5.3)
ROE (ROIC: -17.82)
Altman Z

GENETEC Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.5
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] -42.06
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0.0
Expected Revenue (M) 0.0
Expected Growth (%) 0.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

GENETEC Directors Share Purchases (Beta)


MR TEH KIM SENG reduced 300000.0 units announced on 27 Apr 2023 at ~RM2.78

MR TAN MOON TEIK reduced 1200000.0 units announced on 30 Jan 2023 at ~RM2.72

MADAM ONG PHOE BE reduced 30000.0 units announced on 27 Dec 2022 at ~RM2.68

MADAM ONG PHOE BE reduced 40000.0 units announced on 19 Dec 2022 at ~RM2.71

MR CHIN KEM WENG added 20000.0 units announced on 15 Nov 2021 at ~RM41.9

MADAM ONG PHOE BE reduced 500.0 units announced on 08 Sep 2021 at ~RM29.08

MADAM ONG PHOE BE reduced 5000.0 units announced on 01 Sep 2021 at ~RM29.4

MADAM ONG PHOE BE reduced 5000.0 units announced on 16 Aug 2021 at ~RM25.68

MR TEH KIM SENG reduced 100000.0 units announced on 24 Jun 2021 at ~RM5.67

MR TAN MOON TEIK added 40000.0 units announced on 25 Feb 2021 at ~RM5.51

MR TAN MOON TEIK added 38000.0 units announced on 24 Feb 2021 at ~RM5.66

MR TAN MOON TEIK added 183000.0 units announced on 22 Feb 2021 at ~RM5.55

MADAM ONG PHOE BE reduced 30000.0 units announced on 18 Feb 2021 at ~RM5.58

MR TAN MOON TEIK added 140000.0 units announced on 16 Feb 2021 at ~RM3.89

GENETEC Summary


Market Cap: 221 M.

Market Cap Class: Small caps

Number of Shares: 791 M.

Adjusted Float: 88.7%.

Stock highly correlated with

CEB (92%)

JIANKUN (91%)

PARKSON (91%)

CNASIA (90%)

Genetec Technology Berhad, incorporated in 1997 and headquartered in Bandar Baru Bangi, Malaysia, specializes in the design, development, and manufacturing of intelligent automation systems, serving as a key contract manufacturer for customized factory automation equipment and integrated vision inspection systems. Through its broad capabilities in assembly solutions, material handling, precision tooling, in-house machining, and prototyping, Genetec delivers end-to-end automation solutions across sectors such as electric vehicles and batteries, automotive, semiconductor, consumer electronics, computer peripherals, and healthcare. Its offerings range from conceptual equipment design and prototyping to mass equipment replication, supporting high-precision manufacturing environments. With a focus on innovation and scalability, Genetec operates across Malaysia and serves an international clientele spanning Asia, Europe, and North America.

Sectors: Technology, Trading & Services, Technology Equipment, Semiconductors, Automation, Electric Vehicles, Precision Machining, Penny Stocks

Code: 0104

Website: https://genetec.net

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

GENETEC Top Shareholdings

Updated on 15-Jan-2026

Shareholder % Value (M)
Chin Kem Weng 7.81% 17.3
KVC Corporation Sdn Bhd 6.18% 13.69
Chen Khai Voon 6.04% 13.38
Tan Moon Teik 5.06% 11.22
Chin Kim Weng 4.63% 10.26
Hong Leong Value Fund 3.86% 8.55
Employees Provident Fund Board 2.45% 5.43
Principal Dali Equity Growth Fund 2.37% 5.25
KGI Securities (Singapore) Pte. Ltd. 2.33% 5.16
Sow Ewe Lee 1.6% 3.54
CIMB Bank Berhad 1.47% 3.26
Hong Leong Balanced Fund 1.28% 2.84
Thana Ratnaubonchai 1.14% 2.53
Tan Moon Chong 1.08% 2.39
Phillip Securities Pte. Ltd. 1.05% 2.33
Principal Dali Asia Pacific Equity Growth Fund 0.98% 2.17
Tan Kon Hoan 0.93% 2.06
Leong Kah Kong 0.9% 1.99
Kenanga Shariah Growth Opportunities Fund 0.78% 1.73
Kenanga Growth Fund 0.78% 1.73
Ubs (Lux) Key Selection Sicav-Asian Equities (Usd) 0.76% 1.68
Principal Islamic Small Cap Opportunities Fund 0.76% 1.68
Manulife Investment Shariah Progress Fund 0.75% 1.66
Prulink Strategic Fund 0.74% 1.64
Urusharta Jamaah Sdn. Bhd. 0.69% 1.53
Principal Dali Equity Fund 0.67% 1.48
Principal Dali Opportunities Fund 0.67% 1.48
Chin Kit Sen 0.61% 1.35
Allen Lik-Hook Ting 0.52% 1.15
Frequently Asked Questions
Genetec Technology Berhad, incorporated in 1997 and headquartered in Bandar Baru Bangi, Malaysia, specializes in the design, development, and manufacturing of intelligent automation systems, serving as a key contract manufacturer for customized factory automation equipment and integrated vision inspection systems. Through its broad capabilities in assembly solutions, material handling, precision tooling, in-house machining, and prototyping, Genetec delivers end-to-end automation solutions across sectors such as electric vehicles and batteries, automotive, semiconductor, consumer electronics, computer peripherals, and healthcare. Its offerings range from conceptual equipment design and prototyping to mass equipment replication, supporting high-precision manufacturing environments. With a focus on innovation and scalability, Genetec operates across Malaysia and serves an international clientele spanning Asia, Europe, and North America. The company is listed on Bursa Malaysia and operates in the Technology, Trading & Services, Technology Equipment, Semiconductors, Automation, Electric Vehicles, Precision Machining and Penny Stocks sectors.
Yes, GENETEC TECHNOLOGY BERHAD is listed as Shariah-compliant.
The latest share price of GENETEC TECHNOLOGY BERHAD is RM 0.280 updated on 27 January 2026 16:52.
As of now, GENETEC TECHNOLOGY BERHAD has a market capitalization of 221M based on the latest financial data.
iSaham's technical analysis indicates that GENETEC TECHNOLOGY BERHAD's support level is at RM 0.14 and its resistance level is at RM 0.31, based on moving averages and price patterns.
The 52-week high for GENETEC TECHNOLOGY BERHAD is RM 0.345
GENETEC TECHNOLOGY BERHAD's share price has decreased by -80.14% year-to-date, influenced by market trends and company performance.
Dividend information for GENETEC TECHNOLOGY BERHAD has not been reported yet. Track GENETEC TECHNOLOGY BERHAD's upcoming dividend announcements, yield changes, and payout history easily with the iSaham Stock Screener.
The main shareholders of GENETEC TECHNOLOGY BERHAD include Chin Kem Weng, KVC Corporation Sdn Bhd and Chen Khai Voon. View more on GENETEC TECHNOLOGY BERHAD Top Shareholders page.
You can buy GENETEC TECHNOLOGY BERHAD shares through any licensed online broker or trading platform registered with Bursa Malaysia. If you're new to investing, iSaham can help you open an account with M+ Online, one of Malaysia's leading brokers.
When you open your M+ account through the iSaham team, you can get iSaham Pro for free as a bonus offer.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.